New study implicates disease-driving B cells in fatty liver disease development

(University of Minnesota Medical School) New research from the University of Minnesota Medical School suggests that disease-driving B cells, a white blood cell, play a role in the development of non-alcoholic fatty liver disease (NAFLD) - the most common chronic liver condition in the U.S. Their findings could lead to targeted therapies for NAFLD, which currently affects a quarter of the nation and has no FDA-approved treatments.

https://www.eurekalert.org/pub_releases/2021-03/uomm-nsi032221.php

Source: EurekAlert! - Biology - March 22, 2021 Category: Biology Source Type: news